Edwards Lifesciences (EW) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $0.06.
- Edwards Lifesciences' Debt to Equity fell 570.64% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.06, marking a year-over-year decrease of 570.64%. This contributed to the annual value of $0.06 for FY2024, which is 3314.77% down from last year.
- Per Edwards Lifesciences' latest filing, its Debt to Equity stood at $0.06 for Q3 2025, which was down 570.64% from $0.06 recorded in Q2 2025.
- Over the past 5 years, Edwards Lifesciences' Debt to Equity peaked at $0.13 during Q1 2021, and registered a low of $0.06 during Q2 2025.
- In the last 5 years, Edwards Lifesciences' Debt to Equity had a median value of $0.09 in 2023 and averaged $0.09.
- Its Debt to Equity has fluctuated over the past 5 years, first soared by 60.41% in 2022, then plummeted by 3314.77% in 2024.
- Quarter analysis of 5 years shows Edwards Lifesciences' Debt to Equity stood at $0.1 in 2021, then rose by 0.6% to $0.1 in 2022, then fell by 13.48% to $0.09 in 2023, then crashed by 33.15% to $0.06 in 2024, then decreased by 1.31% to $0.06 in 2025.
- Its last three reported values are $0.06 in Q3 2025, $0.06 for Q2 2025, and $0.06 during Q1 2025.